SOPHARMA AD: Sopharma Consolidated Interim Financial Statements 30.06.2012.

opublikowano: 2012-08-30 14:40

Spis treści:

1. REPORT

2. INFORMATION ABOUT THE ENTITY

3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY


Spis załączników:
SPH_CONSO_Q2-30.06.2012.zip  (REPORT)

POLISH FINANCIAL SUPERVISION AUTHORITY
UNI - EN REPORT No 85 / 2012
Date of issue: 2012-08-30
Short name of the issuer
SOPHARMA AD
Subject
Sopharma Consolidated Interim Financial Statements 30.06.2012.
Official market - legal basis
Art. 56 ust. 1 pkt 1 Ustawy o ofercie - informacje poufne
Unofficial market - legal basis
Contents of the report:
Sopharma Consolidated Interim Financial Statements 30.06.2012.
1. Financial Statements
2. Notes to the Financial Statements
3. Management report
Annexes
File Description
SPH CONSO Q2-30.06.2012.zip SPH CONSO Q2-30.06.2012.zip Sopharma Consolidated Interim Financial Statements 30.06.2012.

SOPHARMA AD
(fullname of the issuer)
SOPHARMA AD Farmaceutyczny (far)
(short name of the issuer) (sector according to clasification
of the WSE in Warsow)
1220 Sofia
(post code) (city)
IlienskoShosse 16
(street) (number)
+359 2 813 42 00 +359 2 936 02 86
(phone number) (fax)
(e-mail) (web site)
nd
(NIP) (REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Date Name Position / Function Signature
2012-08-30 Ognian Donev Executive Director